SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY

被引：40

作者：

Afdhal, N. ^{[1
]}

Everson, G. ^{[2
]}

Calleja, J. L. ^{[3
]}

McCaughan, G. ^{[4
]}

Symonds, W. T. ^{[5
]}

Denning, J. ^{[5
]}

McNair, L. ^{[5
]}

McHutchison, J. G. ^{[5
]}

Arterburn, S. ^{[5
]}

Charlton, M. ^{[6
]}

Reddy, R. ^{[7
]}

Asselah, T. ^{[8
,9
]}

Gane, E. ^{[10
]}

Forns, X. ^{[11
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[2] Univ Colorado Denver, Aurora, CO USA

[3] Hosp Puerta Hierro, Madrid, Spain

[4] Univ Sydney, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia

[5] Gilead Sci Inc, Foster City, CA 94404 USA

[6] Intermt Med Ctr, Murray, UT USA

[7] Univ Penn, Philadelphia, PA 19104 USA

[8] Hop Beaujon, INSERM, U773, Clichy, France

[9] Univ Paris Diderot, Clichy, France

[10] Auckland City Hosp, Auckland, New Zealand

[11] Hosp Clin Barcelona, CIBEREHD, Liver Unit, IDIBAPS, Barcelona, Spain

来源：

关键词：

D O I：

10.1016/S0168-8278(14)60070-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

068

引用

页码：S28 / S28

页数：1